When bringing an idea or innovation into the public domain it is in many cases essential to arrange for proper protection of intellectual property (IP), such as patents and trademarks. A successfully filed patent is a valuable asset.
Please note that it is not possible to receive patent protection when details of an innovation are already in the public domain – which includes scientific literature. So always remember to consider patenting before publishing! The two are not mutually exclusive, though. Applying for patent and publishing your results can be done simultaneously under the proper circumstances. The IXA business developers can advise you in this.
According to the Dutch Patent Act, universities and their medical centres own the rights to discoveries and inventions made by their employees. In their IP regulations they have extended this to discoveries of others, such as interns and externally funded PhD candidates. However, universities and medical centres have developed policies that acknowledge the researchers’ inventorship. In general researchers can look forward to a 1/3 share of the net income from exploitation of the IP rights. All researchers contributing to an intellectual (and original) invention are considered inventors and are mentioned in the patent as such.
The IP regulations of each institution state that any idea, invention or other forms of knowledge that holds the potential for commercial exploitation must be reported to IXA, who will then evaluate whether to protect it, for example through a patent filing. Subsequently, the knowledge can be exploited, for instance through out-licensing to companies, or by starting a spin-off company.
The IXA business developers will inform you of all details and guide you through the process. The business developers will also identify companies or organisations for whom your invention can be interesting. Of course, any activities in this process, for instance in meeting with potential sponsors and licensees, and in helping the patent attorney in the patenting process are taken in close cooperation with you as the inventor.
Optics11 and Optics11 Life have secured funding from Rabobank. The funding will be used to strongly accelerate growth across global markets, to further build the team for the future and to strategically expand the high-tech product portfolios of both business units. “This is the right moment to pick up the pace. Rabobank’s funding helps us […]News
Is it possible to create a cup of coffee that’s healthy and tasty? At the entrepreneurship laboratory Demonstrator Lab at the Vrije Universiteit, Florian Fermin (27) and Stefan Wateler (26) developed Cuppelement, a Fairtrade biodegradable coffee capsule with added superfoods and vitamins. During the Dutch TV program Dragons Den, the entrepreneurs successfully persuaded the dragons […]News
Azafaros B.V. announced today that the first cohort of healthy subjects has been dosed in a two-part Phase 1 clinical study with clinical candidate AZ-3102, a first-in-class small molecule compound being developed for the treatment of rare neurogenetic disorders. This double-blind, placebo-controlled, Phase 1 study is evaluating the safety and tolerability of ascending single- (SAD) […]News